Adam Wilk and Mathieu Martin, Portfolio Manager at Rivemont MicroCap Fund, have a conversation with Nicholas Sosiak, CFO of Cannara Biotech (LOVE.V/LOVFF). This MicroCap Business Breakdowns discussion took place live on July 30th, 2025, on the MicroCapClub Community. https://microcapclub.com/join-now/

Cannara Biotech is a Canadian cannabis company specializing in premium-quality cannabis production at affordable prices. Due to its premium, high quality products, Cannara has emerged as one of Quebec’s fast-growing licensed producers. Cannara grows their product in state-of-the-art facilities, employing methods used in the most sophisticated markets in the world; cultivated from rare genetics, hang dried, slow cured, and hand trimmed. Today, Cannara is recognized for its craft quality at disruptive pricing, and has rapidly carved out market share in Quebec.

Cannara owns and operates two mega Quebec‐based facilities spanning over 1,650,000 sq. ft., providing up to 100,000kg of annualized cultivation output. Cannara’s facilities deliver premium‐quality cannabis from seed to final packaging at affordable retail prices. Cannara is strategically positioned to capitalize on the growing Canadian cannabis market.

Disclaimer: The purpose of this presentation is for informational and educational purposes only and should not be construed as a recommendation to purchase or sell any security. MicroCapClub is not a registered investment advisor. MicroCapClub, its partners, members, subscribers, and affiliates may or may not hold positions in one or more of the securities mentioned on this program and may trade in such securities at any time. Do your own due diligence and seek counsel from a registered investment advisor before trading in any security.